Literature DB >> 8319957

Infantile rhabdomyofibrosarcoma: a high-grade sarcoma distinguishable from infantile fibrosarcoma and rhabdomyosarcoma.

L Lundgren1, L Angervall, G Stenman, L G Kindblom.   

Abstract

Three patients with a predominantly fibrosarcomatous, desmoplastic, and fascicular spindle-cell sarcoma, resembling that of infantile fibrosarcoma but with ultrastructural and immunocytochemical evidence of rhabdomyoblastic differentiation, are described. The tumors were compared light and electron microscopically and immunocytochemically with six classical cases of infantile fibrosarcoma of the desmoplastic type. The three tumors occurred in two girls and one boy who were between 1 and 3 years of age. Ultrastructurally, the tumor cells primarily demonstrated fibroblastic and myofibroblastic features, but there were also tumor cells with sarcomere-like structures. The spindle-shaped, fibroblast-like tumor cells expressed vimentin, desmin, and smooth muscle-specific and sarcomere-specific actins. In one tumor peculiar intracytoplasmic inclusions were observed by light and electron microscopy. The immunocytochemical analysis indicated that these bodies contained all types of thin and intermediate filaments. In short-term cell cultures the tumor cells of two examined tumors revealed immunoreactivity for vimentin, smooth muscle-specific actin, and desmin. Cytogenetically, both tumors displayed a similar chromosomal pattern. One tumor contained two abnormal clones with monosomy 19 and monosomy 22, respectively, and the other tumor revealed a single clone with monosomy 19. In addition, both tumors contained clones with a normal karyotype. Two of the patients with metastatic spread died within 2 years of the primary operation. The third patient is alive with a local recurrence. The three tumors described here deviate from infantile fibrosarcoma in terms of their clinical, ultrastructural, immunocytochemical, and cytogenetic characteristics. The descriptive term "infantile rhabdomyofibrosarcoma" is suggested. The present investigation calls for detailed studies of tumors diagnosed as infantile fibrosarcomas that have metastasized and followed a fatal course.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319957     DOI: 10.1016/0046-8177(93)90017-b

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Misdiagnosed infantile rhabdomyofibrosarcoma: A case report.

Authors:  Tao Pan; Ken Chen; Run-Song Jiang; Zheng-Yan Zhao
Journal:  Oncol Lett       Date:  2016-08-17       Impact factor: 2.967

2.  A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.

Authors:  Rita Alaggio; Lei Zhang; Yun-Shao Sung; Shih-Chiang Huang; Chun-Liang Chen; Gianni Bisogno; Angelica Zin; Narasimhan P Agaram; Michael P LaQuaglia; Leonard H Wexler; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-02       Impact factor: 6.394

3.  DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma.

Authors:  Calogero Virgone; Enzo Lalli; Gianni Bisogno; Elena Lazzari; Josep Roma; Angelica Zin; Elena Poli; Giovanni Cecchetto; Patrizia Dall'Igna; Rita Alaggio
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

4.  Infantile rhabdomyofibrosarcoma: A potentially underdiagnosed aggressive tumor.

Authors:  Narendra Chaudhary; Tanuja Shet; Anupama Borker
Journal:  Int J Appl Basic Med Res       Date:  2013-01

5.  Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript.

Authors:  Marta Colletti; Angela Galardi; Evelina Miele; Virginia Di Paolo; Ida Russo; Cristiano De Stefanis; Rita De Vito; Martina Rinelli; Andrea Ciolfi; Biagio De Angelis; Angelica Zin; Alessandro Guffanti; Maria Cristina Digilio; Antonio Novelli; Rita Alaggio; Giuseppe Maria Milano; Angela Di Giannatale
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.